3,742 results on '"WILDE, ARTHUR"'
Search Results
152. Corrigendum to ‘Syncope in hypertrophic cardiomyopathy (part II): An expert consensus statement on the diagnosis and management’ [International Journal of Cardiology, 2023, 41:180–186]
153. Pushing prognostic boundaries in Brugada syndrome: Trying to predict the unpredictable
154. Management of Congenital Long-QT Syndrome: Commentary From the Experts
155. Gender differences in patients with Brugada syndrome and arrhythmic events: Data from a survey on arrhythmic events in 678 patients
156. The genetic architecture of long QT syndrome: A critical reappraisal
157. Fever-related arrhythmic events in the multicenter Survey on Arrhythmic Events in Brugada Syndrome
158. Genotype and clinical characteristics of congenital long QT syndrome in Thailand
159. The effect of revascularization of a chronic total coronary occlusion on electrocardiographic variables. A sub-study of the EXPLORE trial
160. Lack of genotype-phenotype correlation in Brugada Syndrome and Sudden Arrhythmic Death Syndrome families with reported pathogenic SCN1B variants
161. Clinical Spectrum of SCN5A Mutations: Long QT Syndrome, Brugada Syndrome, and Cardiomyopathy
162. Profile of patients with Brugada syndrome presenting with their first documented arrhythmic event: Data from the Survey on Arrhythmic Events in BRUgada Syndrome (SABRUS)
163. Author Correction: Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility
164. Effect of age and gender on the QTc-interval in healthy individuals and patients with long-QT syndrome
165. Risk scores in congenital long QT syndrome: friend or foe?
166. Sudden Cardiac Death Prediction in Arrhythmogenic Right Ventricular Cardiomyopathy: A Multinational Collaboration
167. Long-term cardiac follow-up of athletes infected with SARS-CoV-2 after resumption of elite-level sports
168. Counterpoint: Ablation in long QT syndrome
169. Cardiac sequelae in athletes following COVID-19 vaccination: evidence and misinformation
170. Optimizing patient selection for primary prevention implantable cardioverter-defibrillator implantation: utilizing multimodal machine learning to assess risk of implantable cardioverter-defibrillator non-benefit
171. Clinical presentation of calmodulin mutations: the International Calmodulinopathy Registry
172. Risk stratification of sudden cardiac death: a review
173. Genetic Burden of TNNI3K in Diagnostic Testing of Patients With Dilated Cardiomyopathy and Supraventricular Arrhythmias
174. Penetrance and Prognosis of MYH7 Variant-Associated Cardiomyopathies
175. Manual versus Automatic Assessment of the QT-Interval and QTc
176. Diagnostic Accuracy of the Standing Test in Adults Suspected for Congenital Long‐QT Syndrome
177. Quality of athlete screening for high‐risk cardiovascular conditions—A systematic review
178. Human Genetics of Cardiomyopathies
179. Prevalence and Clinical Characteristics of Brugada Syndrome
180. Acute and 3-Month Performance of a Communicating Leadless Antitachycardia Pacemaker and Subcutaneous Implantable Defibrillator
181. Yield and Pitfalls of Ajmaline Testing in the Evaluation of Unexplained Cardiac Arrest and Sudden Unexplained Death: Single-Center Experience With 482 Families
182. Channelopathies as Causes of Sudden Cardiac Death
183. Penetrance of Hypertrophic Cardiomyopathy in Children Who Are Mutation Positive
184. The future of sudden cardiac death research
185. Gain-of-function mutation in SCN5A causes ventricular arrhythmias and early onset atrial fibrillation
186. Inherited cardiac arrhythmias
187. Long-term cardiac follow-up of athletes infected with SARS-CoV-2 after resumption of elite-level sports.
188. Insights into adherence to medication and lifestyle recommendations in an international cohort of patients with catecholaminergic polymorphic ventricular tachycardia.
189. Corrigendum to ‘Syncope in hypertrophic cardiomyopathy (part II): An expert consensus statement on the diagnosis and management’ [International Journal of Cardiology, 2023, 41:180–186]
190. Kiosk 3R-FB-04 - Mitral Annular Disjunction in Idiopathic Ventricular Fibrillation Patients: Just a Bystander or a Potential Cause?
191. Age, Sex and Racial Differences in Cardiac Repolarization and Arrhythmogenesis
192. Channelopathy in athletes
193. Abstract 16685: Shared Genetic Pathways Contribute to Risk of Hypertrophic and Dilated Cardiomyopathies With Opposite Directions of Effect
194. Abstract 15884: Life-threatening Arrhythmias With Autosomal Recessive TECRL Variants
195. Transethnic Genome-Wide Association Study Provides Insights in the Genetic Architecture and Heritability of Long QT Syndrome
196. In Children and Adolescents From Brugada Syndrome–Families, Only SCN5A Mutation Carriers Develop a Type-1 ECG Pattern Induced By Fever
197. Heart Rate Recovery After Exercise Is Associated With Arrhythmic Events in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia
198. An International, Multicentered, Evidence-Based Reappraisal of Genes Reported to Cause Congenital Long QT Syndrome
199. Long QT Syndrome, a Diagnosis That Warrants Expert Opinion and Expert Centers
200. A Potential Diagnostic Approach for Foetal Long-QT Syndrome, Developed and Validated in Children
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.